K
Kana Miyazaki
Researcher at Mie University
Publications - 21
Citations - 902
Kana Miyazaki is an academic researcher from Mie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 838 citations.
Papers
More filters
Journal ArticleDOI
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders
Yasufumi Masaki,Lingli Dong,Lingli Dong,Nozomu Kurose,Kazuko Kitagawa,Yuko Morikawa,Motohisa Yamamoto,Hiroki Takahashi,Yasuhisa Shinomura,Kohzoh Imai,Takako Saeki,Atsushi Azumi,Shinji Nakada,Eiji Sugiyama,Shoko Matsui,Tomoki Origuchi,Susumu Nishiyama,Isao Nishimori,Takayuki Nojima,Kazunori Yamada,Mitsuhiro Kawano,Yoh Zen,Masahiko Kaneko,Kana Miyazaki,Kazuo Tsubota,Katsumi Eguchi,Kouichi Tomoda,Toshioki Sawaki,Takafumi Kawanami,Masao Tanaka,Toshihiro Fukushima,Susumu Sugai,Hisanori Umehara +32 more
TL;DR: There are considerable clinical and pathological differences between IgG4+MOLPS and SS, and based on the clinical features and good response to glucocorticoids, a new clinical entity is proposed: IgG 4+MolPS.
Journal ArticleDOI
Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis
Takako Saeki,Shinichi Nishi,Naofumi Imai,Tomoyuki Ito,Hajime Yamazaki,Mitsuhiro Kawano,Motohisa Yamamoto,Hiroki Takahashi,Shoko Matsui,Shinji Nakada,Tomoki Origuchi,Akira Hirabayashi,Noriyuki Homma,Yutaka Tsubata,Takuma Takata,Yoko Wada,Akihiko Saito,Sachiko Fukase,Kunihiro Ishioka,Kana Miyazaki,Yasufumi Masaki,Hisanori Umehara,Susumu Sugai,Ichiei Narita +23 more
TL;DR: It is suggested that renal parenchymal lesions actually develop in association with IgG4-related disease, for which the term 'IgG 4-related tubulointerstitial nephritis' is proposed.
Journal ArticleDOI
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)
Dai Maruyama,Shinsuke Iida,T. Machida,Shigeru Kusumoto,Noriko Fukuhara,Nobuhiko Yamauchi,Kana Miyazaki,Makoto Yoshimitsu,Junya Kuroda,Norifumi Tsukamoto,Hideki Tsujimura,Kensuke Usuki,Takuhiro Yamaguchi,Takahiko Utsumi,Ishikazu Mizuno,Yasushi Takamatsu,Yasuyuki Nagata,Shuichi Ota,Eiichi Ohtsuka,Ichiro Hanamura,Yasuhiro Suzuki,S. Yoshida,Satoshi Yamazaki,Youko Suehiro,Yutaro Kamiyama,Suguru Fukuhara,Kunihiro Tsukasaki,Hirokazu Nagai +27 more
TL;DR: The updated results from preplanned analysis of JCOG1105 with a 3- year follow- up from the end of accrual are reported, suggesting that the twice- weekly dosing of bortezomib in the first cycle along with a higher dose of melphalan influenced the efficacy of the modified MPB regimen in patients with TI- NDMM 1.
Journal ArticleDOI
Improving Prognosis of Aggressive Natural Killer Cell Leukemia in Japan
Ayumi Fujimoto,Takeshi Maeda,Noriko Fukuhara,Kana Miyazaki,Motoko Yamaguchi,Fumihiro Ishida,Ritsuro Suzuki +6 more
TL;DR: The most common first-line chemotherapy was the SMILE regimen (39%), followed by anthracycline-based regimens, mainly CHOP (24%), DeVIC (15%), and other Lasp-containing regimens (8%) as discussed by the authors .
Journal ArticleDOI
Management of elderly patients with malignant lymphoma.
TL;DR: A comprehensive geriatric assessment is a potential tool for determining an appropriate therapeutic approach for each older patient, and incorporating novel targeted agents such as brentuximab vedotin into therapies for older Hodgkin lymphoma patients might be a promising alternative to the anthracycline-containing regimen.